Cesar-Zambia-signing-header

WFH PACT Program: new MOU signed in Zambia

On February 6, 2023, the World Federation of Hemophilia (WFH) and the Ministry of Health (MoH) in Zambia signed a Memorandum of Understanding (MoU) to implement the WFH Path to Access to Care and Treatment (PACT) Program. The Program aims to improve diagnosis, treatment, and care for people with bleeding disorders in Zambia. The MoU is the result of ten years of outreach and advocacy work by the Haemophilia Foundation of Zambia (HFZ), under the leadership of Chairperson Charity Pikiti, and in collaboration with the WFH and the MoH.

Also available in: Français Español

The WFH PACT Program is a 5-year initiative designed to improve outreach and diagnosis and increase access to sustainable care for people with inherited bleeding disorders. This is done through training, education, partnerships, in-country initiatives, and evidence-based advocacy.

The level of care in Zambia has increased significantly over the last few years, thanks to the hard work of many committed stakeholders. The signing of this MoU signifies an exciting new chapter in this journey.

—Cesar Garrido, President, WFH

The MoU was signed as an outcome of the ongoing dialogue between the HFZ, the Zambian MoH and the WFH, with agreement secured during the last visit of the WFH in October 2022 on the ten-year anniversary of the founding of the Haemophilia Foundation of Zambia (HFZ), the Zambian national member organization (NMO). It sets clear objectives for the implementation of the PACT Program over the four years. These objectives include, but are not limited to, increasing the number of people identified with hemophilia and von Willebrand disease (VWD), increasing the proportion of patients on the prophylaxis program, and initiating the procurement of therapeutic products by the government. The HFZ has already begun the initial implementation steps for the Program in close collaboration with the MoH, the key HTCs and the WFH.

“Through this MoU, the government has committed to procure and supply hemophilia treatment products as listed in the essential medicines list,” said Lackson Kasonka, MD, the Permanent Secretary at the Ministry of Health for Zambia. “This is a major step forward and will help us significantly raise the level of care for people with bleeding disorders (PWBDs) in our country.”

To find out more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.

The PACT (Path to Access to Care and Treatment) Program is supported by funding from Roche, our visionary partner; CSL Behring, Pfizer and Sanofi Genzyme, our leadership partners; and Bayer, Biotest and Grifols, our collaborating partners. 

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.